In experimental tumors, overexpression of VEGF-C and VEGF-D induces tumor lymphangiogenesis and promotes tumor metastasis, which can be inhibited by blocking the interaction of VEGFR-3 with its ligands [165,166]. The gene discussed is FLT4; the disease is neoplasm.